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Objective: To determine the efficacy of using pulmonary ultrasound as a diagnostic tool in acute 
dyspnea of undetermined cause compared to the use of serum N-Terminal prohormone Brain 
Natriuretic Peptide (NT-proBNP) in the diagnosis of heart failure. 
 
Design: Systematic literature review 
Methods: Searches were conducted in PubMed and Scopus using the terms pulmonary 
ultrasound and congestive heart failure and studies within the last 10 years. Studies that used 
pulmonary ultrasound compared to BNP as a marker for the diagnosis of heart failure were 
included. 
Results: All three studies found that the use of pulmonary ultrasound was a more specific 
diagnostic aid for heart failure when compared with NT-proBNP. 
Conclusion: The use of pulmonary ultrasound is highly specific in guiding the clinical diagnosis 
of heart failure in patients presenting with acute dyspnea of an unknown cause. 
Introduction 
Heart failure affects 5.7 million adults in the United States.1 Once the diagnosis is made 
half of the affected individuals will not live past five years. The disease also places a tremendous 
economic burden on society, The Center for Disease Control estimates the annual cost of 
hospitalizations for heart failure to be roughly 30.7 billion dollars.1 Common risk factors for 
heart failure include obesity, diabetes and hypertension, all diseases that are on the rise, 
potentially increasing the prevalence of the disease in the not so distant future.  
A diagnosis of heart failure is currently made clinically, largely based on history and 
physical exam. Due to the significant implications of the diagnosis, it is critical that heart failure 
is diagnosed as quickly as possible in dyspneic patients presenting to the Emergency Department 
Several imaging techniques and laboratory findings are currently being used to help the clinician 
make the diagnosis of heart failure, but they are not without flaws. Chest radiographs are 
commonly used to evaluate the lungs for several findings that are related to heart failure. These 
include pleural effusions, interstitial edema, alveolar edema, pulmonary venous blood diversion 
and a widened cardiothoracic ratio.2 These findings are not always present during acute heart 
failure and the sensitivity of chest radiographs is not high enough to make a diagnosis.  
A laboratory value popularly used in the diagnosis of CHF is the measure of N-Terminal 
pro Brain Natriuretic Peptide (NT-proBNP). This biomarker is related to the stretch of the 
ventricular myocytes and an elevated level demonstrates excessive ventricular work and stretch.2 
There are a number of conditions that may be associated with ventricular stretching, including 
acute coronary syndrome, pulmonary embolism, critical illness and old age, which makes this lab 
value highly sensitive but not specific.3 NT-proBNP is able to reliably exclude heart failure in an 
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acute setting with a high sensitivity, however it’s specificity remains variable and generally 
requires confirmatory diagnosis.4 
The use of pulmonary ultrasound has 
been suggested as a tool to assist in making 
the diagnosis of heart failure in the acute 
setting. The examination can be easily 
taught to clinicians and takes about a minute 
to complete.5 Ultrasound is particularly 
appealing as a diagnostic tool, as it is 
readily available, non-invasive and 
relatively inexpensive. It can be performed 
by clinicians who are familiar with the 
technology at the bedside making the 
findings available immediately for clinical 
application.  
Specifically, the presence of diffuse B 
lines on pulmonary ultrasound is an excellent predictor of congestive heart failure. B lines are 
hyperechoic vertical lines seen extending from the pleura to the bottom of the ultrasound screen, 
and they represent thickened interstitium and fluid-filled alveoli.3 An example is included in 
figure 1. Also referred to as comet tail artifacts or lung comets, B lines extend perpendicular to 
the pleural line, radiating down as if in the shape of a comet’s tail.3  
When utilizing pulmonary ultrasound to assess for pulmonary edema, the thorax is 
divided into eight segments and assessed for B-lines in the lung. This technique is an established 
protocol for lung ultrasound created by Cardinale, et al and Volpicelli et al.5,7 Using an eight 
zone test, when all zones are positive, the 
likelihood of CHF is largely increased.3 Each 
thoracic zone is considered positive if three or 
more B-lines are identified in each of the divided 
zones. Subsequently, the ultrasound is considered 
positive for pulmonary edema when two or more 
of these B-line containing zones are adjacent to 
each other.3 In summary, lung ultrasound is 
positive for pulmonary edema when there are two 
adjacent zones that contain three or more B lines 
in each zone. A visual of the pulmonary zone is 
included as figure 2. This indicates pulmonary 
congestion, a result of elevated ventricular pressures 
causing pulmonary interstitial edema.4 
The goal of this meta-analysis is to determine 
whether pulmonary ultrasound improves the 
Figure 1. These arrows depict B lines on 
pulmonary ultrasound examination. 8 
Figure 2. The right anterior chest wall 
divided into 4 zones, PSL is the 
parasternal line, AAL is the anterior 
axillary line, PAL is the posterior axillary 
line. Zones 5 through 8 are contralateral 
equivalents.3 
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specificity and accuracy of the diagnosis of congestive heart failure compared to NT-proBNP. 
Due to the fact that NT-proBNP levels are increased in many non-CHF processes, it is not a 
highly specific lab and therefore a test with increased specificity such as ultrasound is preferred. 
A rapid and highly specific test such as ultrasound is invaluable at the bedside to rapidly 
diagnose congestive heart failure so that proper treatment can be initiated. The studies included 
in this meta-analysis compare these variables with a hope to improve their clinical utility and 
effectively treat patients with acute undifferentiated dyspnea.  
 
PICO  
Population: Adults presenting to the Emergency Setting with acute dyspnea 
Intervention: pulmonary ultrasound  
Control: NT-proBNP  
Outcome: Improved specificity and diagnostic accuracy of Congestive Heart Failure 
 
Clinical Question:  Does the use of pulmonary ultrasound improve specificity and therefore the 
accuracy of the diagnosis of heart failure compared to the use of NT-proBNP (N-terminal 
prohormone Brain Natriuretic 
Peptide)? 
 Methods 
         In September of 2019, 
a literature review search was 
conducted and PubMed and 
Scopus were utilized to 
identify studies evaluating the 
use of bedside pulmonary 
ultrasound in comparison with 
Brain Natriuretic Peptide 
(BNP) for the diagnosis of 
congestive heart failure. The 
search terms “pulmonary 
ultrasound” and “congestive 
heart failure” were used. 
Within PubMed, 297 articles 
were identified based on these 
search terms. Within Scopus, 
33 articles were found based 
on these keywords. We then 
narrowed the search and 
excluded 285 articles that 
Figure 3. PRISMA Flow Diagram 
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were from before the year 2010, not human subjects, not prospective cohort or randomized 
control trials, or not related to congestive heart failure.  
Following this elimination, 45 total articles which were then further narrowed down by 
excluding trials that did not include patients presenting to the Emergency Department with acute 
dyspnea as their chief complaint, and studies that did not specifically compare pulmonary 
ultrasound to NT-proBNP for rapid diagnosis of congestive heart failure.  The remaining 10 
articles were narrowed down based on the strength of statistical studies and number of subjects 
to 3 articles. An overview of the studies found in this review can be found in Table 1, and the 
Prisma flow diagram can be referenced in Figure 3. The articles included in this literature review 
assess the usefulness of point of care pulmonary ultrasound compared to BNP measurement in 
the diagnosis of congestive heart failure in patients presenting with dyspnea to the Emergency 
Setting. 
Results 
Table 1. Comparison of studies in the meta-analysis  
  Study 1: Pivetta et al Study 2: Prosen et al Study 3: Sartini et al 
Year 
Published 
2019 2011 2017 
Sample 
Size 
532 218 255 
Journal European Journal of 
Heart Failure 










14 months 21 months 15 months 
Efficacy 
Outcomes 
Accuracy of diagnosis 
measured by 
sensitivity, specificity, 
PPV, NPV, AUC 
Accuracy of diagnosis 
measured by 
sensitivity, specificity, 
PPV, NPV, +LR, - LR, 
AUC 
Accuracy of diagnosis 
measured by sensitivity, 
specificity, PPV, NPV, 
+LR, -LR, AUC 
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Study 1- Lung Ultrasound integrated with clinical assessment for the diagnosis of acute 
decompensated heart failure in the emergency department: a randomized controlled trial. Pivetta, 
et al.9 
Objective: The purpose of this study was to compare the diagnostic accuracy of lung ultrasound 
versus chest x-ray and NT-proBNP measurements in the correct diagnosis of dyspneic patients 
with congestive heart failure. 
Study Design: This study was a randomized, multi-center trial performed in two Italian 
academic hospitals, Scienza di Torino University Hospital in Turin, Italy and Careggi University 
Hospital in Florence, Italy. The aim of the study was to compare the usefulness of clinical 
examination plus lung ultrasound versus chest x-ray and NT-pro-BNP measurement in diagnosis 
of acute decompensated heart failure (ADHF). The patient population were patients presenting to 
the Emergency Department with acute dyspnea. A secondary outcome was assessing time for 
evaluation for evaluation with pulmonary ultrasound compared to chest Xray and pro-BNP. 
There were 532 patients, deemed eligible if they were over 18 years of age and presenting 
with acute dyspnea defined as sudden onset of shortness of breath, not related to trauma. The 
criteria are described in table 2. The median age of patients was 79 years old. Patients were then 
randomized to be worked up as either the CXR (chest xray)/NT-proBNP group or the LUS 
group. Lung ultrasound (LUS) was performed by a physician, with the presence of three or more 
B lines in an intercostal space representing a positive area of increased lung density. The 
presence of three or more B lines in two or more zones bilaterally was diagnosed as diffuse 
interstitial syndrome. NT-proBNP levels were measured using a commercially available 
immunoassay. 
         Following initial clinical examination, the physician was asked to indicate the presumed 
cause of dyspnea as either ADHF (acute decompensated heart failure) or non-ADHF. CXR and 
NT-proBNP were eventually performed on all patients, but these results were only made 
available to the physician following their initial presumed diagnosis after LUS. Following 
hospital discharge, two expert intensivists who were blinded to LUS results reviewed medical 
records and confirmed ADHF based on the 2012 European Society of Cardiology guidelines for 
heart failure. Time needed to reach diagnosis was also measured and compared in the two groups 









Table 2. Inclusion and Exclusion Criteria for Study 1 
Study Design Pivetta, et al 2015   
Inclusion Criteria Exclusion Criteria 
  
Patients presenting to the Emergency 
Department with acute dyspnea >18 years 
of age 
Patients already mechanically ventilated with 
positive pressure (invasively or non-invasively) at 
time of first evaluation, or acute dyspnea in the 
context of trauma 
 
Study Results: Patients in the group where lung ultrasound was utilized integrated with clinical 
assessment to diagnose ADHF showed higher sensitivity and specificity (93.4%, 95.2%) than 
evaluation with CXR and NT-proBNP (85%, 88.7%). Diagnostic accuracy was also deemed 
higher as demonstrated by an area under the receiver operating characteristic curve (AUC) of 
0.95 compared to AUC of 0.87 with the CXR/ NT-proBNP approach. Results are organized in 
table 3.  
The clinical usefulness of each approach was assessed by evaluating net benefit using 
decision curve analysis. Net benefit quantifies diagnostic gain by showing the benefit of a true 
positive minus the harm of a false positive for ADHF. Net benefit calculations revealed that lung 
ultrasound with clinical assessment would reduce diagnostic errors of ADHF by 7.98 cases per 
100 patients. This was compared to CXR/NT-proBNP with clinical assessment which was shown 
to reduce diagnostic errors by only 2.42 cases per 100 patients.  Assessment with CXR/NT-
proBNP also results in higher false negative diagnoses and false positive diagnoses. Time needed 
to formulate the diagnostic hypothesis of ADHF was also significantly reduced with LUS 
approach. 
         Overall, the study shows that integration of lung ultrasound with clinical assessment is 
more accurate and also offers more benefit than the current recommended diagnostic method of 






Table 3. Results of Study 1; Pivetta et al 2015 
Integrated Evaluation 
Measurements 
CXR/NT-proBNP (N=260) LUS (N=258) 
Sensitivity 85% (95% CI 76.5–91.4%) 93.4% (95% CI 87.5–
97.1%), 
Specificity 88.7% (95% CI 82.5–
93.3%) 
95.2% (95% CI 89.8–
98.2%), 
PPV 83.3% (95% CI 74.7–90%) 95% (95% CI 89.4–98.1%), 
NPV 89.9% (95% CI 83.8–
94.2%) 
93.7% (95% CI 87.9–
97.2%) 
AUC 0.87 (p<0.01) 0.95 (p<0.01) 
 
Study Critique: Some limitations in interpreting the results include the absence of standard 
criteria to determine the final diagnosis of ADHF. This study utilized review of medical records 
by two expert physicians/intensivists with another physician reviewing cases that were disagreed 
upon. The study was unable to perform interobserver measurements for lung ultrasound 
performed by different physicians. However, the authors state that LUS has been shown to have 
high repeatability and reproducibility amongst performers even if they are inexperienced 
sonographers. In another study performed by the same group, a high agreement was 
demonstrated between both experienced and naïve lung ultrasound operators in both acquiring 
and interpreting ultrasound images. 
         Overall, the study had a large patient study group with 532 patients, was a randomized 
control trial, and was generalizable in terms of results. The patient population was diverse with 
multiple comorbidities which is representative of most patients presenting to the Emergency 
Department with ADHF. The ultrasound operators were of varying experience, which represents 
the variety of clinicians in the Emergency Department who may be either expert or new to 
sonography. 
  
Study 2- Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic 
peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and 
asthma as cause of acute dyspnea in prehospital emergency setting. Prosen, et al. 
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Objective: To study the diagnostic accuracy of bedside lung ultrasound (presence of comet-tail 
signs), NT-proBNP and clinical assessment in the differentiation of ADHF related dyspnea from 
other pulmonary related dyspnea. 
Study Design: This was a prospective cohort study performed at the Center for Emergency 
Medicine in Maribor, Slovenia between July 2007 and April 2010. The primary aim of this study 
was to determine the diagnostic accuracy in using the presence of bilateral B-lines on point of 
care lung ultrasound compared to NT-proBNP in assessment of dyspneic patients in the pre-
hospital setting. 
The average age of the group of patients studied was 70.9 years old. There were 218 
patients included in the study, who were deemed eligible if they presented with shortness of 
breath as their primary complaint. Patients were excluded if they were age <18 years, had a 
history of renal insufficiency, trauma, or currently were presenting with severe coronary 
ischemia, pneumonia, pulmonary embolism, carcinoma, pneumothorax, pleural effusion, drug 
intoxication, anaphylactic reaction, upper airway obstruction, bronchial stenosis or GERD. 
Inclusion and exclusion criteria are listed in table 4.  
          Levels of NT-proBNP were measured using a portable Cardiac Reader device. Bedside 
lung ultrasound was performed using a SonoSite portable ultrasound machine. Ten emergency 
physicians performed ultrasound and identified the presence or absence of 3 or more B lines in 
eight zones of the lungs. A positive result was deemed two or more positive zones bilaterally of 
eight measured zones (this is per Cardinale et al and Volpicelli et al examination definitions). All 
physicians who participated had attended a Critical Ultrasound provider course. Measurements 
of NT-proBNP and ultrasound examinations were performed upon arrival to the emergency 
department and before any medications were given. 
         It is the standard of care at this hospital to perform a bedside pulmonary ultrasound in 
patients presenting with acute dyspnea. Physicians in the prehospital setting were blinded to the 
results of NT-proBNP but knew the results of the ultrasound. The study also included internists 
and cardiologists who were blinded to either ultrasound findings or NT-proBNP at the point of 
admission or discharge respectively.   
Table 4. Inclusion and Exclusion Criteria for Study 2 
Study Design Prosen, et al 2011   
Inclusion Criteria Exclusion Criteria 
Shortness of breath as primary 
complaint (defined as sudden onset 
of dyspnea without history of 
chronic dyspnea or increase in 
severity of chronic dyspnea) 
Age <18 years, history of renal insufficiency, trauma, 
severe coronary ischemia, pneumonia, pulmonary 
embolism, carcinoma, pneumothorax, pleural effusion, 
drug intoxication, anaphylactic reaction, upper airway 
obstruction, bronchial stenosis and GERD 
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Study Results: Ultrasound examination alone proved to be more accurate in the accurate 
diagnosis of ADHF and was statistically significant. This was in comparison to both NT-proBNP 
and clinical assessment alone with modified Boston criteria scoring. Lung ultrasound 
examination had 100% sensitivity and 95% specificity in accurate diagnosis of ADHF, in 
comparison to NT-proBNP with 92% sensitivity and 89% specificity. Comparison of the 
methods was made using the x2 test with Bonferroni correction. Results are further explained in 
table 5.  
         Ultrasound examination was found to have an odds ratio of 53.7 with a p value of <0.001 
and 95% confidence interval for the presence of HT. This was in comparison to NT-proBNP 
measurement with an odds ratio of 14.3 and p-value of <0.001. These results demonstrate that 
ultrasound exam was found to be the strongest predictor of ADHF amongst ten significant 
variables that were assessed including orthopnea, rales, and NT-proBNP measurement.  
Table 5. Results of Study 2; Prosen et al 2011 
Measurement NT-proBNP Ultrasound examination 
Sensitivity 92% (95% CI 88 to 95) 
  
100% (95% CI 98 to 100) 
  
Specificity 89% (95% CI 84 to 92) 
  
95% (95% CI 91 to 100) 
  
NPV 86% (95% CI 82 to 90) 100% (95% CI 98 to 100) 
  
PPV 90% (95% CI 85 to 94) 96% (95% CI 93 to 100) 
  
LR+ 8.36 (95% CI 1.72 to 33.86) 
  
20 (95% CI 1.98 to 89.94) 
  
LR- 0.09 (95% CI 0.02 to 0.23) 
  
0 
AUROC 0.90 (95% CI 0.84 to 0.94) 0.94 (95% CI: 0.90 to 0.97) 
OR 14.3 (95% CI 8.1 to 29.4) 53.7 (95% CI, 28.6 to 83.5) 
  
Study Critique: One limitation of this study is that it was performed in a prehospital setting. 
However, in Slovenia where it was performed, there are medical doctors on the ambulances who 
performed the ultrasound and drew the serum markers for NT-proBNP so in essence it was a 
similar setting to an emergency department.        
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The study demonstrated that ultrasound alone has higher sensitivity and specificity than 
NT-proBNP alone and could be used as a diagnostic tool itself for accurate diagnosis of CHF. 
The study also revealed that the combination of ultrasound with NT-proBNP has 100% 
sensitivity, 100% specificity, 100% NPV and 100% PPV for differentiating heart failure 
compared to other pulmonary causes in the prehospital setting. They suggest that if ultrasound 
shows B lines, NT-proBNP should be measured following sonography to confirm the diagnosis. 
         There were five patients who had false positive results with ultrasound examination who 
then went on to have NT-proBNP values of less than 1000 pg/mL and a history of COPD/ 
asthma. This suggests that in a small portion of patients, it is still necessary to confirm the 
absence of ADHF with an NT-proBNP value. While in the majority of cases the study revealed 
that ultrasound examination could be used alone, to achieve complete confidence in the diagnosis 
of ADHF, measurement of NT-proBNP should be performed as well. 
         Overall, this study highlights the fact that pulmonary ultrasound can be utilized in the 
prehospital setting for rapid identification of B lines indicating interstitial pulmonary edema and 
therefore ADHF. This is vital information that can be relayed to the emergency department 
physician upon arrival to the Emergency Department in order to initiate prompt and appropriate 
treatment of ADHF. 
  
Study 3: Which method is best for an early accurate diagnosis of acute heart failure? 
Comparison between lung ultrasound, chest x-ray and NT pro-BNP performance: a prospective 
study. Sartini, et al. 
Objective: To compare and evaluate the performance of chest radiography, NT-proBNP and 
lung ultrasound in identification of acute heart failure in patients presenting to the ED with 
shortness of breath. 
Study Design: This as a prospective observational study performed at the emergency department 
of the University Hospital of Sienna from January 2011 to February 2013. The aim of this study 
was to compare the accuracy in diagnosing heart failure to chest X-ray and NT-proBNP. 
         The average age of the patients was 79.98 years. There were 225 patients in this 
study.  Inclusion criteria for this study included patients over 18 years of age, presenting with 
acute dyspnea (<24 hours) or worsening shortness of breath over a four day period not related to 
trauma. Exclusion criteria for this study included age less than 18 years or dyspnea following 
trauma. The criteria are available in table 6.  
         NT-proBNP was analyzed with ECLIA, Roche Methodics. The NT-proBNP level was 
considered indicative of heart failure when greater than or equal to 300 pg/ml following the 
European Society of Cardiology recommendations. Lung ultrasound was obtained upon initial 
presentation to the emergency department within two hours. The Esaote MyLab30 and MyLab70 
ultrasound machines were used with a variable-band convex array (3.5-5MHz). Six transverse 
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scans of each hemithorax were performed. A positive region was defined by the presence of 3 or 
more B-lines in transverse intercostal planes in two or more regions. The ultrasound was 
performed by emergency room physicians who were blinded to the clinical data. Each physician 
had previously performed at least 50 examinations supervised by an expert before starting the 
study. The results were reviewed by an independent panel of experts made up of two 
cardiologists and an emergency room physician who collected all of the data to determine the 
final diagnosis. 
 Table 6. Inclusion and Exclusion Criteria for Study 3 
Study Design, Sartini et al 2017   
Inclusion Criteria Exclusion Criteria 
Age >18 years, presenting with acute dyspnea (sudden 
onset <24h) or worsening of shortness of breath over a 
4 day period not related to trauma 
Age <18 years, dyspnea following 
trauma 
  
Study Results: The study found that lung ultrasound was more specific than NT-proBNP for 
aiding in the diagnosis of heart failure. The study showed that the specificity of ultrasound is 
greater than that of NT-proBNP. The sensitivity of lung ultrasound was 57.73% and specificity 
was 87.97%. The sensitivity of NT-proBNP was 97.59% and the specificity of 27.56%. Results 
are presented in table 7.  
         This study also reviewed the use of chest x-ray as the sole diagnostic method of heart 
failure. Chest x-ray had a sensitivity of 74.49% and a specificity of 86.26%. The researchers also 
compared the use of two diagnostic tools simultaneously and finally three diagnostic tools at a 
time. These comparisons increased sensitivity and specificity as would be expected. Overall, the 
study found that no test alone could be used to make the diagnosis of congestive heart failure. 
However, the researchers did recommend a step-wise process that starts with chest x-ray and 








Table 7. Results of Study 3; Sartini et al 2017 
Measurement NT-proBNP Ultrasound examination 
Sensitivity 97.59 % (95 % CI 91.57–99.71) 
  
57.73% (95 % CI 47.28–67.70) 
  
  
Specificity 27.56 (95 % CI 20.01–36.19) 
  
87.97 % (95 % CI 81.20–92.96) 
  
NPV 94.59 % (95 % CI 81.81–99.34) 
  
74.05 % (95 % CI 66.49–80.69) 
  
PPV 46.82 % (95 % CI 39.21–54.54) 
  
77.78 % (95 % CI 66.4–86.73) 
  
LR+ 1.351 (95 % CI 20–1.51) 
  
4.80 (95 % CI 2.94–7.83) 
  
LR- 0.09 (95 % CI 0.02–0.35) 
  
0.48 (95 % CI 0.38–0.61) 
  
AUROC 75.5% 84% 
 
Study Critique: The study enrolled 42 patients who had previously received diuretic therapy in 
the prehospital setting prior lung ultrasound, however, they also measured both sensitivity and 
specificity in those who had not been treated. In the patients who had not been treated ultrasound 
had a higher sensitivity and specificity when compared to the entire study population as would 
be expected.   
         This study divided the hemithorax into 6 regions but found that studying only four 
provided higher yield information. They based this finding on the dependent nature of pulmonary 
edema. This is a limitation of the study as other studies used 8 quadrants to evaluate each 
hemithorax.  Cardinale et al and Volpicelli et al have set up defined quadrants and findings that 
allow for a consistent pulmonary ultrasound evaluation. The lack of following these established 
criteria is a limitation of this study. 
         The study also identified a small sample size of patients given the frequency of patients 
with dyspnea presenting to the emergency room. They suggested enrolling more patients to 
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improve the ability to generalize the findings. A larger sample size will improve any studies 
ability to generalize findings and this is an area that could be improved in the study of pulmonary 
ultrasound use and the diagnosis of heart failure.  
         Overall, this study did an excellent job of isolating the variables and blinding the 
observers to other findings. It also showed that lung ultrasound can be accurately performed even 
by providers with minimal training. 
Discussion 
         Congestive heart failure is a growing cause of morbidity and mortality. As with all 
medical maladies, making the diagnosis quickly and accurately is imperative for positive 
outcomes. The diagnosis of heart failure is unique in that it is often made based on clinical 
suspicion rather than a clearly defined laboratory test. In patients presenting to the emergency 
department with acute dyspnea, a rapid and accurate diagnosis of heart failure can decrease the 
time needed to treat patients which will in turn lead to improved long-term outcomes.  
NT-proBNP has been used to improve the accuracy of a heart failure diagnosis but is 
limited in its ability to accurately rule in CHF by a myriad of factors. Examples of artificially 
high and low causes of BNP have been defined by Yoo, BS11 in table 8. While this biological 
marker has utility, a more definitive test is needed. Ultrasound is a commonly used technology 
that is easily adaptable to aid in the diagnosis of heart failure. With minimal additional training 
the use of bedside ultrasound can provide a fast and reliable view of the lungs and be used to 
enhance the clinical diagnosis of heart failure leading to faster treatment and improved outcomes. 
The aim of our study was to compare the diagnostic utility of pulmonary ultrasound to NT-
proBNP in accurately reaching the diagnosis of heart failure. 
Table 8. Factors Affecting BNP; Yoo, BS 2014 
Factors that can account for high BNP levels and no CHF 
- Age, Sex, Renal Failure, Myocardial Infarction, Acute large pulmonary embolism 
Factors that can account for low BNP levels with CHF 
- Obesity (BMI>30 kg/m2), Flash pulmonary edema, CHF secondary to causes upstream 
from the left ventricle (Acute mitral regurgitation, Mitral stenosis), Stable NYHA class I 
patients with low ejection fractions 
 
         All three studies showed that pulmonary ultrasound was a more specific diagnostic aid 
than NT-proBNP. Ultrasound has the advantage of allowing an indirect visualization of the 
thorax and potential pathology such as fluid accumulation. This is compared to the serum marker 
NT-proBNP, which is only an indirect measure of the response to pathology. In all three studies 
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NT-proBNP was found to have a lower specificity compared to the use of pulmonary ultrasound. 
These findings are significant as they show that pulmonary ultrasound is an effective tool in 
making the diagnosis of heart failure. 
         The limitations of this review include the setting ultrasound was performed. The aim was 
to determine the use of pulmonary ultrasound in the emergency room in acute dyspneic patients 
with an unclear diagnosis. Pivetta et al. and Sartini, et al. reflected this in their studies. However, 
Prosen et al. performed their pulmonary ultrasound and serum markers in a prehospital setting, 
while they still found ultrasound to be a better diagnostic aid, the prehospital environment and 
the emergency room are unique settings which may limit the transferability of the results. 
 Another limitation identified is the procedure used during pulmonary ultrasound. A 
standardized approach has been established but Sartini, et al. deviated from this technique 
possibly altering the results of their study. It would be beneficial for future studies to utilize a 
consistent pulmonary ultrasound technique such as created by Cardinale, et al and Volpicelli et 
al. In this review, only one study was a randomized control trial (Pivetta et al), this may be seen 
as a limitation. Additional randomized control trials would lend enhanced credibility to the use 
of lung ultrasound in the diagnosis of heart failure. 
 To evaluate the overall utility of pulmonary ultrasound as a diagnostic test, likelihood 
ratios were calculated for each study using sensitivity and specificity and compared in Table 9. A 
positive likelihood ratio gives a quantifiable value to determine the likelihood that a disease state 
is present given a positive result from the diagnostic test. In all of the studies in this review the 
positive likelihood ratio of ultrasound was higher when compared to the positive likelihood ratio 
of NT-proBNP. The positive likelihood ratios demonstrate the favorable use of pulmonary 
ultrasound in making the diagnosis of heart failure compared to NT-proBNP.  
 Overall, this meta-analysis demonstrates that pulmonary ultrasound is a highly specific 
test that can be used in practice in the assessment of patients presenting emergently with acute 
dyspnea. The presence of three or more B-lines in two adjacent thoracic zones confers high 
specificity for acute decompensated heart failure. Pulmonary ultrasound results in fewer false 
positives than NT-proBNP and is therefore incredibly useful at the bedside to aid in the diagnosis 
of CHF. The ramifications of this conclusion are that pulmonary ultrasound can and should be 
used as a diagnostic aid in the initial assessment of patients with acute dyspnea.  
 
Table 9. Positive Likelihood Ratios of BNP and LUS  
  Positive LR BNP  Positive LR LUS  
Pivetta, et al9 7.5 19.5 
Prosen, et al6  8.36 20 
Sartini, et al10 1.35 4.80  
 16 
Conclusion 
         These studies show that lung ultrasound is an effective tool compared to the serum 
marker NT-proBNP in aiding in the diagnosis of heart failure. NT-proBNP has a lower 
specificity and less utility in initial diagnosis. In regard to pulmonary ultrasound, each study 
found that the presence of three or more B-lines in two adjacent thoracic zones confers a high 
specificity to the diagnosis of heart failure. This demonstrates that lung ultrasound is an effective 
tool for use in the assessment of the patient with acute dyspnea of undetermined cause. This 
meta-analysis shows that pulmonary ultrasound should be used in patients presenting to the 
emergency department with undifferentiated acute dyspnea before the use of NT-proBNP. If the 
pulmonary ultrasound results are equivocal an NT-proBNP can be ordered to aid in diagnosis as 
a second line diagnostic tool. This stepwise protocol prevents unnecessary lab orders with results 
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